More recent studies in rodent models of migraine have further explored a mechanistic role of DRD2 using receptor agonist and antagonists; DRD2 antagonism reversed acute migraine-response metrics including allodynia, CGRP levels, and brainstem c-fos activation [140]. Here, FOS is linked to migraine disorder.